I don't think pima would get a partnership yet so I'm thinking this has something to do with Allergan. Don't know if you ever followed Icagen but when their collaboration ended with Pfizer there was a short term renewal..(I think that already happened here with Allergan) and then Pfizer just took out the whole company. Allergan has been with Acadia forever....Acadia might hedge this and go for a buyout. If Pima ends up working I'm sure the deal will be structured in a way that provides value for that. I love pimavanserin but so far the data isn't on our side. However, a partnership for pima in antipsychotic induced weight gain could be really exciting.
Don't know....I'm feeling good about the potential for Allergan to step up and do something here.